Randall Pellish MD
Inflammatory Bowel Disease
Director, Lahey Inflammatory Bowel Disease Center. Assistant Professor of Medicine, Tufts University Medical School
Join to View Full Profile
Lahey Hospital & Medical Center41 Burlington Mall RdBurlington, MA 01805
Phone+1 781-744-8740
Dr. Pellish is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Randall Pellish is a gastroenterologist at the Lahey Hospital and Medical Center in Burlington, MA where is the director of the Inflammatory Bowel Disease Center. He received his medical degree from UMass Chan Medical School and has been in practice 16 years. He specializes in inflammatory bowel disease (Crohn's and ulcerative colitis) and is highly experienced in general gastroenterology, gastrointestinal bleeding, and endoscopy.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Gastroenterology, 2005 - 2008- Rhode Island Hospital/Brown University HealthChief Residency, Internal Medicine, 2004 - 2005
- Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2001 - 2004
University of Massachusetts Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2008 - 2027
NH State Medical License 2024 - 2026
RI State Medical License 2002 - 2008
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Roles: Principal Investigator
- A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet Start of enrollment: 2022 Jun 30
Roles: Principal Investigator
Publications & Presentations
PubMed
- Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade™) versus Biosimilar Infliximab (Renflexis™) for...Joseph M Cappuccio, Neev Mehta, Randall Pellish
Digestive Diseases. 2024-01-01 - Discordance Between Inflammatory Bowel Disease Specialists and Insurance Authorization Denials-A Survey of Specific Inflammatory Bowel Disease Treatment Scenarios.Anastasia Naritsin, Neev Mehta, Randall Pellish
Crohn's & Colitis 360. 2024-01-01 - 2 citationsAcute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis.Karim T Osman, Asahi Hoque, Ravi Teja Pasam, Adel Farhoud, Ahmed Abdelfattah
BMC Gastroenterology. 2023-05-22
Press Mentions
AI Being Used to Perform Molecular Analysis of Biopsies from Bowel Disease PatientsJuly 12th, 2022
IBD Center Aims to Help Patients with Crohn’s and ColitisNovember 4th, 2019- The Difference Between a Gluten Sensitivity and Celiac DiseaseOctober 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
